Read + Share
Lohr B, Niemann D, Verheyen J. Bamlanivimab Treatment Leads to Rapid Selection of Immune Escape Variant Carrying
the E484K Mutation in a B.1.1.7-Infected and Immunosuppressed Patient. Clin Infect Dis 2021;73:2144-2145.
PMID: 34009286
|
 |
|
Lohr B, Niemann D, Verheyen J. Bamlanivimab Treatment Leads to Rapid Selection of Immune Escape Variant Carrying
the E484K Mutation in a B.1.1.7-Infected and Immunosuppressed Patient. Clin Infect Dis 2021;73:2144-2145.
PMID: 34009286
|
|
|
|